- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-1 antibody
Total 53600 results
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Head and Neck Neoplasms | Colorectal NeoplasmsAustralia, Hong Kong
-
Adanate, IncRecruiting
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingRenal Cell CarcinomaAustralia, United States, Canada, Chile, Taiwan
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaCanada, United States, Australia, Belgium, Brazil, Chile, France, Germany, Israel, Italy, Japan, Poland, South Africa, Spain, Switzerland, United Kingdom
-
PDC*line Pharma SASActive, not recruitingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCNon Small Cell Lung CancerBelgium, France, Netherlands, Germany, Poland
-
Merck Sharp & Dohme LLCRecruitingCarcinoma, Non-Small-Cell LungUnited States, Australia, Brazil, Chile, China, Costa Rica, Dominican Republic, Germany, Greece, Guatemala, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Spain, Turkey, Portugal, Romania, South Africa, Philippines, Ukr...
-
Shanghai Zhongshan HospitalRecruitingHepatocellular CarcinomaChina
-
BeiGeneActive, not recruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma (HNSCC) | Nasopharyngeal Carcinoma (NPC)Canada, Australia, New Zealand, Korea, Republic of, United States, Malaysia, Thailand
-
Ascletis Pharmaceuticals Co., Ltd.RecruitingHIV Infections | HIV-1-infection | PD-L1 Gene MutationChina
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | Granulocyte Colony-Stimulating FactorChina
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.Completed
-
Merck Sharp & Dohme LLCRecruitingHodgkin LymphomaAustralia, Israel, Korea, Republic of, Spain, Poland, Sweden, United Kingdom, Turkey, China, United States, Brazil, Germany, Belgium, France, Switzerland, Canada, Czechia, Chile, Argentina
-
Merck Sharp & Dohme LLCRecruiting
-
Merck Sharp & Dohme LLCActive, not recruitingHead and Neck NeoplasmsPoland, Canada, Brazil, Belgium, Japan, United States, Argentina, Australia, Austria, Chile, Colombia, France, Germany, Hungary, Ireland, Israel, Korea, Republic of, Portugal, Russian Federation, Spain, Switzerland, Taiwan, Ukraine, United...
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerUnited States, Australia, France, Germany, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminatedGastric Neoplasms | Gastroesophageal Junction AdenocarcinomaChina, Korea, Republic of, Malaysia, Taiwan
-
Merck Sharp & Dohme LLCCompleted
-
Xuanwu Hospital, BeijingUnknownNon-small Cell Lung Cancer | PD-1 Antibody | Lung Cancer Stage II
-
Mahmoud Ramadan mohamed ElkazzazNot yet recruiting
-
Waterstone Hanxbio Pty LtdCompletedAdvanced Solid TumorAustralia
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingBreast Cancer | Triple-Negative Breast CancerChina
-
Fukushima Medical UniversityKanagawa Cancer CenterUnknown
-
Merck Sharp & Dohme LLCActive, not recruitingEsophageal Squamous Cell Carcinoma (ESCC) | Gastroesophageal Junction Carcinoma (GEJC) | Esophageal Adenocarcinoma (EAC)China, Canada, United States, Argentina, Belgium, Brazil, Chile, Czechia, Denmark, Estonia, France, Germany, Guatemala, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Philippines, Portugal, Romania, Russian Federation and more
-
HotSpot Therapeutics, IncRecruitingSolid Tumor, Adult | Relapsed Cancer | Refractory CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Germany, Thailand, France, Belgium, China, Argentina, Greece, Turkey, Malaysia, Portugal, Hungary, Brazil, United States, India
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.CompletedCholangiocarcinoma | Biliary Tract CancerChina
-
Second Affiliated Hospital of Soochow UniversitySciClone PharmaceuticalsRecruitingAdvanced Solid Tumor | Refractory TumorChina
-
Women's Hospital School Of Medicine Zhejiang UniversityRecruitingStudy of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined ChemotherapyGestational Trophoblastic NeoplasiaChina
-
Peking UniversityNot yet recruiting
-
Chinese PLA General HospitalRecruitingHodgkin Lymphoma | Anti-PD-1 Antibody ResistantChina
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Australia, United States, Turkey, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate Cancer
-
Fudan UniversityRecruiting
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.RecruitingTriple Negative Breast CancerChina
-
Affiliated Cancer Hospital & Institute of Guangzhou...Not yet recruitingNon Small Cell Lung Cancer | EndostatinChina
-
Huazhong University of Science and TechnologyUnknown
-
Merck Sharp & Dohme LLCRecruiting
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedSquamous Cell CarcinomaCanada, United States, Australia, France, Germany, Israel, Mexico, Norway, Spain, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Istari Oncology, Inc.Active, not recruiting
-
Fudan UniversityRecruitingPancreatic CancerChina
-
Fudan UniversityNot yet recruitingTriple-negative Breast Cancer